Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1010103-16-8

Post Buying Request

1010103-16-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1010103-16-8 Usage

Classification

Indazole derivative

Contains

Nitro group and a fluorine atom

Potential applications

Medicinal chemistry and pharmacology

Use

Building block in the synthesis of pharmaceutical drugs

Possible properties

Various pharmacological properties

Reactivity

Contributed by nitro and fluorine functional groups

Interactions

Potential interactions with biological systems

Importance

Compound of interest for further research and development

Check Digit Verification of cas no

The CAS Registry Mumber 1010103-16-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,0,1,0 and 3 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1010103-16:
(9*1)+(8*0)+(7*1)+(6*0)+(5*1)+(4*0)+(3*3)+(2*1)+(1*6)=38
38 % 10 = 8
So 1010103-16-8 is a valid CAS Registry Number.

1010103-16-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-fluoro-4-nitro-1H-indazole

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1010103-16-8 SDS

1010103-16-8Upstream product

1010103-16-8Downstream Products

1010103-16-8Relevant articles and documents

INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1

-

Paragraph 00146, (2016/01/25)

The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compou

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1010103-16-8